Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
AKTIENPREIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionGraham Capital Management, L.P.
Latest Disclosed Ownership183,547 shares
Latest Disclosed Value $ 418,487
Graham Capital Management, L.P. reports 29.48% increase in ownership of 9EH / Evolent Health, Inc.

On May 15, 2026 - Graham Capital Management, L.P. filed a 13F-HR form disclosing ownership of 183,547 shares of Evolent Health, Inc. (DE:9EH) valued at $346,904 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 141,759 shares of Evolent Health, Inc.. This represents a change in shares of 29.48% during the quarter. The current value of the position is $620,389 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EVOLENT HEALTH CL A 30050B101 183,547 41,788 29.48 418 -26.28 0.0101
2026-02-17 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 141,759 80,156 130.12 567 8.83 0.0136
2025-11-14 2025-09-30 13F EVOLENT HEALTH CL A 30050B101 61,603 61,603 521 0.0082
2025-08-14 2025-06-30 13F EVOLENT HEALTH CL A 30050B101 0 -19,062 -100.00 0 -100.00
2025-05-15 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 19,062 -26,532 -58.19 181 -64.84 0.0032
2025-02-14 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 45,594 45,594 513 0.0077
2024-11-14 2024-09-30 13F EVOLENT HEALTH CL A 30050B101 0 -82,423 -100.00 0 -100.00
2024-08-14 2024-06-30 13F EVOLENT HEALTH CL A 30050B101 82,423 28,905 54.01 1,576 -10.21 0.0343
2024-05-15 2024-03-31 13F EVOLENT HEALTH CL A 30050B101 53,518 37,035 224.69 1,755 222.43 0.0330
2024-02-14 2023-12-31 13F EVOLENT HEALTH CL A 30050B101 16,483 16,483 544 0.0121
2023-05-15 2023-03-31 13F EVOLENT HEALTH CL A 30050B101 0 -19,719 -100.00 0 -100.00
2023-02-14 2022-12-31 13F EVOLENT HEALTH CL A 30050B101 19,719 -10,135 -33.95 554 -48.41 0.0168
2022-11-14 2022-09-30 13F EVOLENT HEALTH CL A 30050B101 29,854 12,041 67.60 1,072 95.98 0.0424
2022-08-15 2022-06-30 13F EVOLENT HEALTH CL A 30050B101 17,813 7,095 66.20 547 58.09 0.0221
2022-05-16 2022-03-31 13F EVOLENT HEALTH CL 30050B101 10,718 10,718 346 0.0119
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.